Average Co-Inventor Count = 5.43
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (20 from 3,923 patents)
20 patents:
1. 12226405 - Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
2. 11702409 - Pyrazolyl derivatives useful as anti-cancer agents
3. 10786492 - Formylated N-heterocyclic derivatives as FGFR4 inhibitors
4. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
5. 10189813 - Formylated N-heterocyclic derivatives as FGFR4 inhibitors
6. 10130629 - Pharmaceutical combinations
7. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
8. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
9. 9604981 - IP receptor agonist heterocyclic compounds
10. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
11. 9266883 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
12. 9174985 - Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists
13. 9169251 - Pyrrolopyridine derivatives and their use as CRTH2 antagonists
14. 9115129 - Substituted pyrido[2,3-B]pyrazines as IP receptor agonists
15. 9079897 - Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors